drugset / Trial / NCT03249272

Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve

NCT03249272 ↗

Phase 4 Terminated 31 enrolled Duke University
RandomizedParallel-groupSingle-blindBasic science

Summary

The aim of this study is to assess microvascular function as determined by a cardiovascular magnetic resonance measurement of whole-heart (global) perfusion reserve. The goal is to determine the prevalence of MVD in two common forms of non-ischemic cardiomyopathy, hypertrophic cardiomyopathy (HCM) and idiopathic dilated cardiomyopathy (IDCM). The hypothesis that an optimized technique will provide robust detection of MVD and that a multifaceted approach will provide new insights into the pathophysiology of MVD, including the influence of myocardial scarring upon the presence and severity of MVD.

Timeline

Start
2017-09-05
Primary completion
2019-03-31
Completion
2019-03-31

Outcome

Outcome not reported

Stopped (Business): “Sponsor withdrew funding”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adenosine Small molecule — —
Comparator Regadenoson Diagnostic / imaging agent — —